Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
0 hedge funds and large institutions have $0 invested in Bio-Path Holdings Inc in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
1.22% less ownership
Funds ownership: 1.22% → 0% (-1.2%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $5.29K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XTX Topco
George Town,
Cayman Islands
|
-$5.29K |
BPTH Hedge Fund Activity: Q2 2025 in Review
0 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2025, worth a combined $0 — down 100% from $5.29K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BPTH and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was XTX Topco, exiting entirely with an estimated $5.29K sold.
- 0 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2025, down from 2 in Q1 2025.
- Funds reported $0 of Bio-Path Holdings Inc stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Bio-Path Holdings Inc positions in Q2 2025 and 2 closed out, a net change of -2 holders.
- The largest Bio-Path Holdings Inc seller in Q2 2025 was XTX Topco, an estimated $5.29K sold.
Based on aggregated 13F filings for Q2 2025.